Results 1 to 10 of about 743,427 (163)

Cardiovascular Hospitalizations and Resource Use Following Atrial Fibrillation Ablation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Over the next few years, atrial fibrillation (AF)–related morbidity and costs will increase significantly. Thus, it is prudent to examine the impact of AF treatment on health care resource use.
Mehak Dhande, Amr Barakat, Ann Canterbury, Floyd Thoma, Suresh Mulukutla, Ahmet Sezer, Konstantinos N. Aronis, Aditya Bhonsale, Krishna Kancharla, Andrew H. Voigt, Norman C. Wang, Alaa Shalaby, N. A. Mark Estes, Samir Saba, Sandeep K. Jain   +14 more
doaj   +1 more source

Fibroblast Growth Factor 21 Protects Against Atrial Remodeling via Reducing Oxidative Stress

Frontiers in Cardiovascular Medicine, 2021
Aim: The structural and electrical changes in the atrium, also known as atrial remodeling, are the main characteristics of atrial fibrillation (AF). Fibroblast growth factor 21 (Fgf21) is an important endocrine factor, which has been shown to play an ...
Miao Chen, Jiawei Zhong, Zhen Wang, Hongfei Xu, Heng Chen, Xingang Sun, Yunlong Lu, Lu Chen, Xudong Xie, Liangrong Zheng   +9 more
doaj   +1 more source

Ibandronate promotes autophagy by inhibiting Rac1–mTOR signaling pathway in vitro and in vivo

Cell Death Discovery, 2022
We previously reported that ibandronate (IBAN) could improve endothelial function in spontaneously hypertensive rats. However, the mechanism by which IBAN improves endothelial function is unclear.
Jie Han, Jian Yang, Qiqi Wang, Xiang Yin, Zewei Sun, Chaoyang Huang, Guoping Chen, Liangrong Zheng, Dongmei Jiang   +8 more
doaj   +1 more source

Obstructive sleep apnea and atrial fibrillation: insights from a bidirectional Mendelian randomization study

BMC Medical Genomics, 2022
Background Observational studies have suggested that obstructive sleep apnea (OSA) is in relation to atrial fibrillation (AF); however, these studies might be confounded and whether the relationship is causal remains unclear. We conducted a bidirectional
Lu Chen, Xingang Sun, Yuxian He, Yunlong Lu, Liangrong Zheng   +4 more
doaj   +1 more source

Effectiveness of catheter ablation of atrial fibrillation according to heart failure etiology

Journal of Arrhythmia, 2020
Background Catheter ablation is an important rhythm control therapy in patients with atrial fibrillation (AF) with concomitant heart failure (HF). The objective of this study was to assess the comparative efficacy of AF ablation patients with ischemic vs
Eric Black‐Maier, Benjamin A. Steinberg, Kevin M. Trulock, Frances Wang, Yuliya Lokhnygina, Wanda O'Neal, Sana Al‐Khatib, Brett D. Atwater, James P. Daubert, Camille Frazier‐Mills, Donald D. Hegland, Kevin P. Jackson, Larry R. Jackson, Jason I. Koontz, Robert K. Lewis, Albert Y. Sun, Kevin L. Thomas, Tristram D. Bahnson, Jonathan P. Piccini   +18 more
doaj   +1 more source

Comparative performance of CHA2DS2VASc and anticoagulation and risk factors in atrial fibrillation risk scores for predicting mortality in patients with COVID-19

International Journal of the Cardiovascular Academy, 2021
Background: The AnTicoagulation and Risk factors in Atrial fibrillation (ATRIA) and CHA2DS2VASc risk scores used to detect the thromboembolic and hemorrhagic risk in atrial fibrillation (AF) patients has been shown recently to predict poor clinical ...
Dilay Karabulut, Ersan Oflar
doaj   +1 more source

Catheter ablation of atrial fibrillation in patients with diabetes mellitus

Heart Rhythm O2, 2020
Background: Diabetes mellitus (DM) is an independent risk factor for atrial fibrillation (AF). Few studies have compared clinical outcomes after catheter ablation between patients with and those without DM.
Allen Wang, MD, Tracy Truong, MB, Eric Black-Maier, MD, Cynthia Green, PhD, Kristen B. Campbell, PharmD, Adam S. Barnett, MD, Janice Febre, BSN, RN, Zak Loring, MD, MHS, Sana M. Al-Khatib, MD, MHS, FHRS, Brett D. Atwater, MD, James P. Daubert, MD, FHRS, Camille Frazier-Mills, MD, MHS, Donald D. Hegland, MD, Kevin P. Jackson, MD, Larry R. Jackson, MD, Jason I. Koontz, MD, PhD, Robert K. Lewis, MD, PhD, Sean D. Pokorney, MD, MBA, Albert Y. Sun, MD, Kevin L. Thomas, MD, Tristam D. Bahnson, MD, FHRS, Jonathan P. Piccini, MD, MHS, FHRS   +21 more
doaj   +1 more source

Safety and Cost Implications of Same-Day Discharge Following Elective Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defects in Australia

Hearts, 2021
Background: Percutaneous closure of patent foramen ovale (PFO) and atrial septal defects (ASD) is being more commonly performed due to changes in international guidelines supporting its use.
Abhisheik Prashar, Sanjana Shah, Richard Zhang, Kurt Mitchell, Mark Sader   +4 more
doaj   +1 more source

Complete Transthoracic Echocardiography for the Assessment and Guidance of Percutaneous Atrial Septal Defect Closure in Adults without Balloon Sizing: An Observed Study with a 10-Year Follow-Up

Journal of Cardiovascular Development and Disease, 2023
Objectives: This study aims to determine if complete transthoracic echocardiography (TTE)-guided percutaneous atrial septal defect (ASD) closure without balloon sizing could be safe and efficacious in adult patients. Methods: A total of 551 patients with
Lin-Feng Xie, Yong Lin, Mei-Fang Chen, Gui-Can Zhang   +3 more
doaj   +1 more source

A new algorithm to diagnose atrial ectopic origin from multi lead ECG systems - insights from 3D virtual human atria and torso [PDF]

, 2015
Rapid atrial arrhythmias such as atrial fibrillation (AF) predispose to ventricular arrhythmias, sudden cardiac death and stroke. Identifying the origin of atrial ectopic activity from the electrocardiogram (ECG) can help to diagnose the early onset of ...
Alday, Erick A. Perez, Butters, Timothy D., Colman, Michael A., Hancox, Jules C., Higham, Jonathan, Langley, Philip, Workman, Antony J., Zhang, Henggui   +7 more
core   +2 more sources